Physician profile
Benjamin J Cunningham
NPI 1568452084
$9,029.37
in general payments reported to CMS, 2019-2025
23 companies · $2,410 in 2025
The $2,410 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,608 · 2020: $72.26 · 2021: $1,632 · 2022: $338 · 2023: $605 · 2024: $365 · 2025: $2,410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,538 · Travel and Lodging: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,538.17 |
| Travel and Lodging | $840.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $3,005.35 | 2019-2025 | Tfn-Advance, Velys |
| Depuy Synthes Sales INC. | $1,792.57 | 2019-2025 | Na, Orthovisc, Va-Lcp |
| Pylant Medical | $1,200.00 | 2021 | |
| Stryker Corporation | $1,186.80 | 2019-2024 | T2 Alpha |
| Zimmer Biomet Holdings, INC. | $676.28 | 2019 | |
| Si-Bone, INC. | $221.87 | 2022-2023 | |
| Bioventus LLC | $158.17 | 2019-2025 | Gelsyn-3, Exogen Ultrasound Bone Healing System |
| Davol INC. | $119.33 | 2025 | Arista, Surgiphor |
| Arthrex, INC. | $113.00 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $112.23 | 2021 | |
| Smith+Nephew, INC. | $96.25 | 2021-2023 | Pico 14 |
| Orthofix Medical, INC. | $51.38 | 2022-2025 | Physio-Stim |
| Integra Lifesciences Corporation | $50.84 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kls-Martin L.P. | $50.11 | 2020 | |
| Lifenet Health | $37.02 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $27.03 | 2023 | Ethicon, Dermabond Prineo, Vistaseal |
| Medtronic USA, INC. | $24.79 | 2019 | |
| Innovation Technologies INC | $24.15 | 2023 | Irrisept |
| Pfizer INC. | $21.56 | 2025 | |
| Vericel Corporation | $17.27 | 2022 | |
| Rattan and Associates | $16.99 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $13.74 | 2023 | Seglentis |
| Biocomposites INC | $12.64 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.